FDA
-
-
-
-
-
-
-
Aptevo reports 100% remission rate in AML trial cohort 3
-
-
-
-
-
-
-
Aptevo Therapeutics Reports 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
-
-
-
-
-
-
-
Pre-Open Movers 11/15: (QURE) (ARNA) (NBEV) Higher; (MARK) (JCP) (NTAP) Lower (more...)
-
-
-
-
-
-
-
After-Hours Stock Movers 09/28: (AERH) (APVO) (PTCT) Higher; (NXST) (HLT) Lower (more...)
-
-
-
322,963 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

